First-time generic drug approvals, May 2008
Generic drugs approved by FDA (through May 2008) including amifostine for injection, clobetasol foam, granisetron oral solution, calcium acetate capsules, and irinotecan injection.
Amifostine for injection, 500 mg (equiv to Ethyol for injection)
SUN
Clobetasol foam, 0.05% (equiv to Olux foam)
PERRIGO
Granisetron oral solution, 2 mg (base)/10 mL (equiv to Kytril oral solution)
CYPRESS
Irinotecan injection, 20 mg/mL (equiv to Camptosar injection)
WATSON
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen
